These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 308390)

  • 1. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
    Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
    Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma.
    Parmiani G; Meschini A; Invernizzi G; Carbone G
    J Natl Cancer Inst; 1978 Nov; 61(5):1229-34. PubMed ID: 81882
    [No Abstract]   [Full Text] [Related]  

  • 4. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 7. Expansion of tumor-specific cytolytic T lymphocytes using in vitro restimulation with tumor-specific transplantation antigen.
    Naito K; Pellis NR; Kahan BD
    Cell Immunol; 1987 Sep; 108(2):483-94. PubMed ID: 3113743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 9. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. II. Analysis of the clonal progeny of CTL precursors stimulated in vitro with syngeneic tumor cells.
    Brunner KT; MacDonald HR; Cerottini JC
    J Immunol; 1980 Apr; 124(4):1627-34. PubMed ID: 6154076
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current topics on tumor immunology].
    Tachibana T
    Gan No Rinsho; 1983 Oct; 29(13):1492-8. PubMed ID: 6608013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration in vitro of cytotoxic T cells with apparent specificity toward tumor-specific transplantation antigens on chemically induced tumors.
    Chauvenet PH; McArthur CP; Smith RT
    J Immunol; 1979 Dec; 123(6):2575-81. PubMed ID: 315425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.
    Glaser M
    J Natl Cancer Inst; 1978 Nov; 61(5):1351-5. PubMed ID: 213615
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
    Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
    J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
    Evans R
    Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stimulatory effects of bearing primary methylcholanthrene-induced tumors upon the murine lymphoreticular system.
    Smith RT; Konda S
    Int J Cancer; 1973 Nov; 12(3):577-88. PubMed ID: 4598649
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogens.
    Fritze D; Kern DH; Humme JA; Drogemuller CR; Pilch YH
    Int J Cancer; 1976 Jan; 17(1):138-47. PubMed ID: 1248898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.
    Bowlin TL; Proffitt MR
    Cancer Immunol Immunother; 1982; 13(1):30-7. PubMed ID: 6984353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.